Lung sarcoma

Lung sarcoma is a malignant neoplasm that affects lung tissue and metastasizes to other organs. Consider the features of this disease, diagnostic methods, treatment methods, and survival prognosis.

Unlike other types of cancer, sarcoma is characterized by increased aggressiveness, rapid growth and division of mutated cells.

As a rule, lung sarcoma is a tumor lesion of the mesoderm, i.e. connective tissue. Unlike other malignant diseases, it is characterized by very rapid growth and distant metastases. Sarcoma has two types, which determine the degree of malignancy of the neoplasm:

• Low grade malignancy – such neoplasms originate from highly differentiated cells that divide slowly. The neoplasm contains few malignant elements and a lot of stroma.
• High degree of malignancy – sarcoma originates from poorly differentiated cells that divide quickly and frequently. Such cells contain many malignant elements and little stroma. The tumor is characterized by a well-developed vascular network and the presence of necrotic foci.

Lung sarcoma is characterized by a high degree of malignancy, although the neoplasm itself is a rather rare disease. Thus, according to medical statistics, there are about 100 cases of cancerous lung lesions per one lung sarcoma. That is, it accounts for 1% of all malignant lung lesions, but is characterized by high malignancy. As a rule, sarcoma originates from the connecting interalveolar septa or bronchial walls. Most often, the upper lobes are affected (part of the lobe or the entire lobe), but complete lung damage is also possible.

The lung consists of many structures and elements, has connective tissue. Lung sarcoma combines many other types of neoplasms, which are divided by the degree of differentiation.

Highly differentiated:

• Angiosarcoma - affects the blood vessels of the lung, its different layers and walls. It is the most common neoplasm.
• Chondrosarcoma – originates from cartilaginous tissue, usually developing from the third germinal layer of the lung.
• Fibrosarcoma - can develop from the connective tissue of the bronchi or surrounding tissue. It is the second most common.
• Neurosarcoma – develops from connective tissue, which is part of the nerve trunks.
• Hemangiopericytoma – originates from the cells that surround blood vessels – pericytes.
• Lymphosarcoma is the third most common neoplasm and develops from the tissue of the lymph nodes.
• Liposarcoma is rare and originates from adipose tissue.
• Rhabdomyosarcoma and leiomyosarcoma are neoplasms of the striated muscles and smooth muscle tissue of the lungs.

Undifferentiated sarcomas are cells from which they develop at different stages of development, so their further functions are not defined. That is, one cell can become part of muscle tissue or enter into the composition of a tendon. Undifferentiated cancers behave unpredictably, quickly and often metastasize, metastases spread hematogenously, that is, with the blood flow. As a rule, spindle cell, round cell and polymorphic cell sarcomas are encountered.

[ 1 ], [ 2 ], [ 3 ], [ 4 ], [ 5 ]

Causes of lung sarcoma

The causes of lung sarcoma are not fully understood, but there are a number of factors that provoke the appearance of neoplasms and other malignant neoplasms.

• Air with a high content of carcinogens (gas, soot, exhaust) is the main cause of lung sarcoma.
• Heredity – lung sarcoma can develop already in childhood. Predisposition to malignant neoplasms and the influence of provoking factors lead to the appearance of a tumor.
• Bad habits, especially smoking.
• Poor ecology and high doses of radiation have a negative impact not only on the lungs, but also on the overall functioning of the body.

Quite often, lung sarcoma appears out of nowhere, without any apparent reason, spontaneously. The etiology of this disease is sometimes difficult to identify. However, the most promising causes can be voiced:

• Burdened heredity. A person whose family has already had cases of this disease needs to undergo preventive examinations more often, since there is a high risk of cancer in other blood relatives.
• Chemical carcinogens: Minimize the use of household chemicals at home, avoid toxic gases that can be inhaled.
• Take medications with caution. Do not self-medicate.
• Limit ionizing radiation: avoid prolonged exposure to the scorching rays of the summer sun, and visit the solarium in moderation.
• Bad habits, and in particular smoking.
• Environmental pollution.
• Receiving significant doses of radiation.

[ 6 ], [ 7 ], [ 8 ], [ 9 ], [ 10 ]

Symptoms of lung sarcoma

Lung sarcoma can manifest itself at any age, but, as observations have shown, this pathology is more common in white-skinned people. At the same time, the risk age is after forty years.

So what are the symptoms of lung sarcoma?

• The person begins to quickly lose strength, the body's fatigue increases. Shortness of breath appears, caused by hypertrophy of the right side of the heart.
• Dysphagia. Difficulty swallowing food and liquids. Metastasis has also penetrated the esophagus.
• Nausea and vomiting.
• Headache and dizziness.
• Cramps.
• Hoarseness of voice.
• Increase in the size parameters of the tumor formation.
• Pathology of the small (pulmonary) circle of blood circulation appears as a consequence of congestive processes occurring in the lungs.
• Pleurisy. Frequent manifestations of inflammatory processes in the pleura, both cold and infectious in nature, are observed.
• There is a syndrome of compression of the superior vena cava, which occurs under the influence of a growing tumor, or due to an increase in the size of the heart muscle.
• The patient constantly complains of cold symptoms (long-term, protracted pneumonia), which do not go away even when taking medications.
• As a result of tumor growth and its metastasis to neighboring organs, the symptoms of lung sarcoma may be further supplemented based on which organ has been affected by the pathological effect.

The symptoms are practically no different from the clinical symptoms of lung cancer. The intensity of the symptoms depends on the size of the tumor, its location and stage of development. As a rule, patients complain of rapid fatigue, shortness of breath, difficulty swallowing food, pleurisy. Hypertrophy of the right heart is possible due to blood stagnation in the lungs. The growth and development of sarcoma causes compression of the superior vena cava. Patients may have long-term pneumonia, which is untreatable. In the late stages, the symptoms become generalized, cause cachexia and metastasize.

Lung sarcoma is very rare, but it occurs more often in older men than in women and, as a rule, affects the left lung. According to medical statistics, the most common cause of neoplasm is work associated with occupational hazards (finger, chemicals, radiation exposure) and bad habits, namely smoking.

Lung sarcoma can be either primary, i.e. develop from lung tissue, or secondary, which is a metastasis of sarcoma from other organs and parts of the body. The secondary form is more common, it is detected much earlier than the main tumor site. Since the symptoms are similar to those of lung cancer, the patient develops an unbearable cough, shortness of breath and copious sputum with blood. But unlike cancer, sarcoma causes an increase in body temperature, severe general weakness and paleness of the skin.

Metastasis of sarcoma to the lung

Metastases of sarcoma to the lung are a fairly common phenomenon that occurs with tumor lesions of the mammary gland, thyroid gland, liver, intestine. Metastases to the lungs can appear with various types of neoplasms, hypernephromas, melanomas, seminomas and chorionepitheliomas; they can have the form of a single node, but more often multiple up to 5-6 cm in diameter, have a white or gray-pink color, partial pigmentation in brown-black is possible.

Metastases to the lung may form branching and diffuse networks in the lung tissue and under the pleura. Such metastasis is typical of cancerous lymphangitis. In rare cases, metastases cause miliary lymphogenous carcinomatosis of the lung. In aspiration metastases, the tumor disintegrates in the upper respiratory tract or grows into adjacent tissues. Metastatic nodes in the lungs can repeatedly metastasize to other organs and tissues.

• Metastases of sarcoma in the lungs may not make themselves known for a long time and may not cause painful symptoms. Most often, the tumor lesion is detected during a routine preventive chest X-ray examination.
• Symptoms appear if the pleura and bronchi are involved in the tumor process. In this case, the patient suffers from chest pain, dry cough with phlegm, hemoptysis is possible, and an increase in body temperature over a long period of time.
• Symptoms of lung damage cause general deterioration of condition, weight loss. The course largely depends on the primary tumor, multiple or single lesions and previous treatment.

If metastases in the lungs are multiple, then X-ray reveals large-focal foci of compaction of the lung tissue of a round shape with clear outlines, which are scattered throughout the lung, but most often in the peripheral parts. Hematogenous small-focal metastasis is possible. With multiple lesions, single metastases of a round shape with clear outlines, up to 10 cm in size, occur.

If sarcoma metastases to the lung grow into large bronchi, this leads to bronchostenosis. When conducting an X-ray examination, the lesion looks like primary lung cancer. Solitary and multiple metastases can disintegrate, forming cavities of varying thickness. Most often, the cavity of disintegration occurs closer to the periphery of the metastatic tumor node. If metastasis has a lymphogenous spread, the picture is similar to cancerous lymphangitis. When conducting an X-ray examination, sarcoma metastases look like expansions and compactions of roots that penetrate into the lung tissue, fan-shaped scattering and forming a thin mesh. Small nodular shadows are clearly visible against the background of the mesh pattern.

For diagnosis, anamnesis data, clinical examination of other organs and systems are of particular importance. Biopsy and differential diagnostics with lung cyst, benign lung lesion, primary lung cancer and pneumonia are mandatory.

Treatment of sarcoma metastases to the lungs depends on the type of tumor lesion. Thus, in case of solitary metastases that appear after treatment of the primary tumor, i.e. after a long period of time, surgical treatment is used. The patient is removed a segment or lobe with a tumor node. In case of multiple metastases in the lungs, the patient is given chemotherapy or prescribed hormonal drugs that are sensitive to the main tumor.

Radiation therapy is used for multiple metastases, lung seeding with cancer cells in Ewing's sarcoma, Kaposi's sarcoma, osteogenic and reticulosarcoma. This type of treatment can be used if surgical treatment is impossible. In all other cases, symptomatic therapy is used for treatment. Metastases of sarcoma to the lungs have a poor prognosis. Patient survival for a long period of time is possible with the removal of the primary tumor and a full course of therapy.

Kaposi's sarcoma of the lungs

Kaposi's sarcoma of the lungs is a systemic disease that most often affects the skin and mucous membranes. But with this type of neoplasm, internal organs and the lymphatic system are affected. The defeat of the lungs by Kaposi's sarcoma occurs against the background of the spread of cancer cells throughout the body, that is, as a result of metastasis, although isolated lung damage is also possible.

The disease is characterized by non-specific clinical symptoms: sudden weight loss, fever. Patients may complain of pleural chest pain, shortness of breath, hemoptysis, stridor (heavy, noisy breathing). X-ray examination reveals bilateral (parenchymatous, interstitial) infiltrates. The tumor has unclear outlines, massive pleural effusion.

To confirm Kaposi's sarcoma, differential diagnostics and lung tissue biopsy are performed. The patient undergoes transbronchial and endobronchial biopsy, bronchial brush biopsy and pleural examination. Patients are found to have typical manifestations of Kaposi's sarcoma, which look like damage to the trachea and bronchial tree.

Diagnosis of lung sarcoma

Any doctor will agree that the earlier the disease is diagnosed, the brighter the prognosis awaits the patient. This is especially true for oncological diseases. The insidiousness of cancer is that it can only be detected at early stages of development by chance, since cancerous neoplasms at the initial stage of development do not manifest themselves in any way: no pain symptoms, the person feels quite satisfactory. Therefore, the patient consults a doctor when painful symptoms begin to appear, and this is, most often, an advanced, severe stage of the disease.

How is lung sarcoma diagnosed?

• Clinical studies: Blood tests in advanced disease show elevated ESR and varying degrees of anemia.
• Magnetic resonance imaging (MRI). Allows to determine the classification of the lesion, tumor parameters, and its shape.
• Computed tomography.
• X-ray examination of the lungs. It also allows determining the size and shape of the lung and the presence of cancerous formation, the nature of the lesion.
• Electrocardiogram (ECG) – it is necessary to monitor the function of the heart.
• Radioisotope study. Allows to obtain the difference in the quantitative content of isotopes in healthy and cancerous tissues.
• Angiography. Monitoring of disorders in the functioning of the blood vessel system.
• Biopsy. Taking samples for histological examination to determine the type of cancer cells.
• Doppler examination of the functioning of the heart and blood vessels of the pulmonary circulation system.

[ 11 ], [ 12 ], [ 13 ]

Treatment of lung sarcoma

Treatment of lung sarcoma is divided into several stages.

Surgical treatment of lung sarcoma

It is performed in case of local lung damage and can lead to complete recovery. This type of treatment allows to eliminate painful symptoms, increases patient survival, and has a palliative nature. During surgical intervention, endarterectomy of sarcoma can be performed, the entire lung or its lobe can be removed.

Surgical intervention involves the removal of a neoplasm within healthy tissue. If the patient's condition is severe and abdominal surgery is impossible, doctors use a radiosurgical method of removal. For this, a cyber scalpel or gamma knife is used, which are a type of radiotherapy. The use of high-tech methods gives a positive effect in the treatment of lung sarcoma.

In any manifestations of oncology, including lung cancer, oncologists strive for complete removal of tumor tissue. This method, with local placement and a small area of coverage, allows the patient to fully recover, otherwise, to alleviate the patient's condition and prolong his life.

Based on the clinical picture, the oncologist surgeon resects the entire tumor along with the adjacent tissues. But such an operation is justified if the cancerous tumor is local and has not metastasized to other areas of the lung, capturing large volumes. If the affected area is significant, then the surgical intervention may be absolutely ineffective.

An oncologist, planning or not planning an operation, based on the picture and severity of the pathology revealed by the diagnostics. But there are also some criteria that do not allow surgical intervention.

Doctors consider the following to be contraindications for surgery for lung sarcoma:

• Heart failure.
• Kidney failure.
• Pleural pathology.
• Tumor growth beyond the lung.
• General weakness of the body.
• Metastasis to other areas of the human body.
• And many other factors.

If all indications indicate that the operation must be performed, the oncologist surgeon determines the operation plan and its scale, since surgical intervention can be gentle (wedge resection), when a segment of the lung is resected, as well as more extensive, if it is necessary to remove the entire lung. Naturally, it is impossible to completely remove both lungs. Therefore, when considering each specific case, the doctor is obliged to weigh all the pros and cons and come to the best solution. The result of the operation: to leave as much healthy lung tissue as possible, while resecting as much cancer-affected matter as possible. This allows the patient to better adapt to life in new physiological conditions of the body's functioning. This also reduces the likelihood of repeated relapses. That is, the result of surgery for lung sarcoma largely depends on the competence and experience of the operating oncologist surgeon.

In addition to the tumor and nearby tissues, lymph nodes that fall into the area of localization of the pathology are usually removed. This helps prevent the likelihood of relapse and gives the patient a good chance of recovery.

Chemotherapy for lung sarcoma

This type of treatment is as important as surgery. Chemotherapy can destroy sarcoma metastases in the lung and significantly reduce the size of the primary tumor. Adequately selected chemotherapy drugs reduce the rate of sarcoma development. Chemotherapy can be performed both before and after surgery. Radiotherapy is used to remove metastases in other organs and is very often combined with stereotactic radiosurgical methods.

Treatment, as with cancer lesions, is combined. Very often, chemotherapeutic, immunotherapeutic and surgical methods are used for treatment. But unlike cancerous tumors, sarcoma is more resistant to the action of chemotherapy drugs. That is why much attention in the treatment process is paid to radiotherapy.

Of course, to this day there is an opinion that lung sarcoma is incurable. But modern equipment, effective methods of treatment and diagnostics allow to cure sarcoma and increase the life expectancy of the patient. Do not forget about foreign clinics, sarcoma treatment in medical centers of Israel is especially popular and highly effective.

The use of antitumor drugs allows to improve the patient's quality of life and, if not cure completely, at least prolong his life. It is mainly prescribed after surgery, and if the operation is ineffective, it is included in a complex of therapeutic measures that should help improve the patient's condition, remove the negative manifestations of the lesion. And in some cases, this is the only method of treatment (for an inoperable tumor).

How effective chemotherapy will be in treatment depends largely on the results of histology, which should determine the type of cancer cells:

• if histology shows small cell cancer, then the use of chemotherapy drugs will significantly reduce symptoms and bring relief to the patient;
• In the case of large cell cancer, such drugs are not as effective and require the use of additional methods of influencing the cancer cell.

This method of treatment allows to achieve:

• Progressive reduction in the size parameters of the primary tumor (before surgery).
• Removal of "free-standing" mutated cells and small tumors that were not destroyed during surgery.
• If surgery is not advisable, medications are used to reduce the intensity of symptoms.

Chemotherapy is carried out in courses, with breaks for the patient to restore his strength and immune system. The number of such cycles varies and depends on the pathology and its severity. Most often, it is seven to eight times. The attending physician selects drugs for each patient individually. Sometimes the course of treatment consists of a complex of several drugs, which allows for the effect of each drug to be enhanced.

Here are some chemotherapy drugs used to treat lung sarcoma:

• Prospidin

This medicine must be taken under close supervision of the attending physician. During the administration of the drug, which is dripped into a vein or slowly injected intramuscularly, and for another half hour after the procedure, the patient must lie down.

The starting dosage prescribed to the patient is strictly individual and is 0.05 g for an adult. The administration is carried out once a day or every other day. After three to six days, the dose of the drug is increased to 0.15–0.2 g daily. The therapeutic course dosage is 6 g. If the result obtained is not effective enough, the dosage is increased to 0.25–0.3 g and radiation therapy is added to the treatment protocol.

During chemotherapy, it is necessary to exclude all contacts of the patient with carriers of the infection. The drug is administered by qualified personnel under the supervision of an oncologist, observing all precautions.

This drug should not be prescribed to patients suffering from hypersensitivity to the components of the drug, with severe forms of renal and hepatic insufficiency, with vascular pathology and other diseases.

• Interferon

To stop inflammatory processes in the upper respiratory tract and lungs, the doctor prescribes a drug of this type to the patient. The course of treatment lasts until the risk of infection has passed, or until the symptoms of an existing inflammation have completely disappeared. This remedy is consumed as a solution. It is prepared immediately before use (the maximum shelf life is up to two days), diluting the drug (2 ml) with boiled or distilled water at room temperature.

The resulting composition is introduced into the nasal cavity or sprayed with a spray. Five drops are dripped twice a day, with the period between doses not being less than six hours. If the medicine is sprayed, about 250 ml is sprayed into each nasal passage. These are prophylactic doses.

If treatment is necessary, the dosage is increased. The sooner you start taking the drug, the more effective it will be. Inhalation procedures are also possible, which can be carried out both through the mouth and nose. One procedure requires three ampoules, which are mixed with 10 ml of boiled or distilled water at a temperature of no more than 37 ° C. The patient receives inhalation twice a day, the interval between these procedures is one to two hours. Instillation or spraying of the drug into the nasal cavity is carried out in the same dosages as for preventive measures, but the interval between doses is reduced to one to two hours. The number of such doses during the day should be at least five. It is advisable to take the drug for two to three days.

This medicine has no side effects or contraindications.

• Avastin

The drug in question is administered only intravenously using a dropper. It is diluted to the required consistency with 0.9% sodium chloride solution, observing all sterility requirements. It is necessary that the resulting composition contain the active substance of the drug in a solution of 1.4-16.5 mg / ml.

The initial dose of the drug is taken after the first chemotherapy, subsequent doses are possible both before and after taking chemotherapy drugs. The drug is dripped quite slowly: from 60 to 90 minutes.

Avastin intake is accompanied by quite serious side effects: increased blood pressure, anemia, constipation, nausea and vomiting, bleeding, exacerbation of problems with the gastrointestinal tract and cardiovascular system, manifestation of various dermatitis and much more. This drug is strictly contraindicated for people with increased sensitivity to the components of the drug, women during pregnancy and lactation.

• Chlorbutin

The dosage and duration of cycles are determined individually for each patient based on the patient’s clinical picture and general condition.

The drug is prescribed in doses depending on the number of leukocytes found in the blood serum.

• if the amount of enzymes in the blood is within the range of 30.0–40.0x10 ⁹ /l, then 0.008–0.010 g of the drug is administered to the patient at one time;
• if the leukocyte count in the blood is 15.0–20.0x109/l, then the single dose is 0.006–0.008 g;
• in the case where the quantitative composition falls within the range of 10.0–15.0x10 ⁹ /l, the dose of the administered drug will be 0.004–0.006 g;
• at a leukocyte level of 5.0–10.0x109/l, the dose is 0.004 g.

To avoid irreversible negative processes, the maximum dosage of the course should not exceed 6.5 mg calculated per kilogram of the patient's weight. If the level of leukocytes in the blood has dropped to 2.0–2.5x109/l, the patient is transferred to a lower dose of the drug (0.002 g), which is taken one to three times a day.

It is not advisable to use the drug in question for people who suffer from severe gastrointestinal diseases, acute liver and kidney failure, and for women during pregnancy.

[ 14 ], [ 15 ], [ 16 ], [ 17 ], [ 18 ]

Radiotherapy for lung sarcoma

The method of radiation exposure to mutated cells is used as a component of complex treatment. Radiation therapy for lung sarcoma is considered by oncologists to be the most effective method of influencing cancer cells. Most often, radiotherapy is used in one protocol together with chemotherapy, but these methods are not interchangeable.

It is this combination that is most productive, for example, in stage four lung sarcoma.

Cyber Knife

This is one of the innovative methods of treating lung cancer, which is already quite actively used in such developed countries as Japan, Israel, America, Germany and others.

This method does not violate the integrity of the chest and skin, but affects cancer cells by irradiating them with X-rays. Using the latest advances in medicine in this area, a modern oncologist can accurately recreate a tumor model: its size and location, which allow for a high degree of accuracy influencing only cancer cells directly, destroying them. But you should not perceive the cyber knife as a panacea. Although using it together with other methods, good results are obtained that allow you to prevent further tumor development and destroy existing mutated cells. This prolongs the patient's life and makes it better.

[ 19 ], [ 20 ], [ 21 ]

Folk treatment of lung sarcoma

Classical medicine does not deny the use of folk remedies for lung sarcoma, but they can only be used with the consent of your doctor. Sarcoma is quite aggressive and progresses very quickly. In this situation, the main thing is not to delay the time, since self-medication with folk methods takes a lot of time, which may not be enough to save the patient's life. It is also difficult to find a universal recipe that would be suitable for any histological type of tumor. It cannot be completely stated that folk methods of treating lung cancer are ineffective, but they should definitely complement the main classical treatment, and not be the only method of treatment.

[ 22 ], [ 23 ], [ 24 ], [ 25 ], [ 26 ], [ 27 ]

Palliative treatment of lung sarcoma

It is impossible to talk about a single treatment plan for oncology. Doctors most often use a set of methods that are used simultaneously. If the severity of the disease is at stage four, it is almost impossible to completely destroy the cancerous tumor. Then the attending physician uses all methods that can alleviate the patient's condition. This includes pain relief, oxygen therapy, and others.

Prevention of lung sarcoma

Prevention of lung sarcoma is carried out to prevent the development of the disease. Primary and secondary prevention are distinguished. Let us consider these types of disease prevention in more detail:

Primary prevention

This type of prevention is called oncohygienic. The patient undergoes a set of medical and hygienic measures aimed at reducing and eliminating risk factors that increase the risk of sarcoma. Prevention involves combating air pollution, both at home and at work.

The most important stage of primary prevention is quitting smoking. Promoting a healthy lifestyle and quitting bad habits can reduce the occurrence of malignant neoplasms by tens of times. It is protection from tobacco smoke that reduces the risk of developing sarcoma. Minimizing passive smoking is another method of preventing sarcoma.

Secondary prevention

This type of prevention includes clinical and medical methods. Patients undergo routine preventive examinations of the lungs and treatment of precancerous processes. There are certain risk groups that require special monitoring to prevent lung sarcoma. The risk group mainly includes men who smoke, have long-term tuberculosis, pneumonia or chronic bronchitis. Those at particular risk are long-term smokers over 50 years of age who have previously undergone treatment for malignant neoplasms.

Prevention of lung sarcoma consists of early diagnosis of the disease. People at risk undergo computed tomography and X-ray examination. Surgical treatment of malignant neoplasms is also a method of prevention and prevents the occurrence of metastases.

It is quite difficult to advise anything in this direction. Today, prevention can be reduced to some actions that can, if not prevent the disease, then at least detect it in the early stages. During such a period, it is easier to treat, and the patient receives a brighter prognosis for the future.

• If a person often suffers from colds, pneumonia, pneumonia; if the temperature rises to alarming levels, then it is necessary to be wary and it is advisable to undergo a full medical examination in a specialized oncology center.
• It is necessary to lead an active, healthy lifestyle: stop smoking…
• Monitor your immunity.

Prognosis of lung sarcoma

Quite a lot depends on the type of tumor and the degree of neglect of the disease shown by the clinical picture during diagnosis. If the tumor is represented by cancer cells of high differentiation and they mutate at an insignificant rate, the prognosis of lung sarcoma in this case will be positive.

Thanks to a comprehensive approach to the treatment of lung sarcoma, the use of the latest developments, the percentage of patients who managed to survive for five years increases (up to 5-10% of the total number of cases of the disease). With timely surgery and an effective postoperative period, a complete recovery can occur.

Lung sarcoma responds well to treatment, but it also has the highest percentage of relapses with extensive metastasis.

The prognosis depends on the size of the malignant neoplasm, the location of the neoplasm and its type, as well as the general health of the patient.

Sarcoma has the most aggressive growth, early and rapid metastasis. The survival rate of patients with sarcoma, but without proper treatment, is from 3 to 5 months. This suggests that patients with sarcoma can die about six months after diagnosis. Sarcoma is insensitive to chemotherapy, the success of recovery and a positive prognosis largely depend on early diagnosis of the disease.

Successful treatment of any malignant tumors is of great importance, as they can metastasize to the lungs. Very often, when sarcoma is detected, it has a secondary origin, that is, it occurs as a result of metastasis from other tumor foci. Rapid diagnosis and timely treatment significantly increases the life expectancy of patients, and therefore gives a positive prognosis for the disease.

How long do people live with lung sarcoma?

When faced with this pathology, relatives and friends, and even the patient himself, ask themselves the same question: “How long do people live with lung sarcoma?”

Cancer treatment is a complex task. And as sad as it may sound, it is lung sarcoma that has the highest percentage of fatal outcomes. With effective treatment, the percentage of patients who survive for about five years is quite high, but only a small percentage of patients survive for more than five years. If treatment is not carried out or the disease is diagnosed too late, the lifespan of such a patient is only two to four months.

Life expectancy depends largely on:

• From the type of tumor, determined by histology. For example, small cell cancer is often determined only at the late stages of the disease, while it grows quickly and metastasizes. It is this that gives the highest percentage of deaths. Large cell cancer allows for a favorable prognosis.
• The size parameters of the tumor also play a significant role here.
• How extensive is the clinical picture of metastasis of cancer cells to neighboring organs. With a large area of damage, treatment may no longer be effective.

Thus, stage I of the disease takes 50-60% of patients, when diagnosed at stage II of the disease, 70-85% of patients cross the threshold of death.

Life expectancy depends on early diagnosis and treatment effectiveness. As a rule, 5-10% of patients with sarcoma survive. Lung sarcoma has an unfavorable prognosis compared to other types of malignant diseases. Thus, the five-year survival rate is 3-17%.

Lung sarcoma is one of the most dangerous and difficult to treat malignant neoplasms. The tumor develops quickly and metastasizes early, so early diagnosis and timely treatment are important for successful treatment. We should not forget about preventive measures that can prevent neoplasms.

Lung sarcoma is a terrible disease that takes the largest number of patients' lives. But there is no need to despair. It is necessary to fight to the last, because modern medicine offers a fairly large arsenal of methods designed to help cancer patients not only overcome this insidious disease, but also lead a person to a normal, familiar life in the future. Each of us is only required to pay more attention to our health, undergo preventive examinations on time and, at the slightest suspicion of a disease, immediately contact a clinic.